EUVIMEDEUVIMED entdecken
Crossref

Prepregnancy GLP ‐ 1RA Exposure and Risk of Hypertensive Disorders of Pregnancy Among Women With Obesity and Diabetes

Dominick J Lemas iD, Ruben Zapata iD, Isaac Loy, Aditya Mahadevan, Tony Wen iD, Rahma Mkuu, Adetola Louis-Jaques iD, Jaclyn Hall iD, Kylie K Harrall, Larissa Strath iD, Amy Sheer, Elizabeth Shenkman und 3 weitere

Obesity · 2026

DOI: 10.1002/oby.70221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Obesity, 2026. Verfasst von Dominick J Lemas und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Obesity, Diabetes Mellitus, Type 2, Pre-Eclampsia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: NIDDK NIH HHS, National Center for Advancing Translational Sciences of the National Institutes of Health, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) are prescribed to women of reproductive age for obesity, type 2 diabetes, obstructive sleep apnea, and more. Data on pregnancy outcomes following prepregnancy exposure remain limited. We evaluated associations between prepregnancy GLP‐1RA exposure and maternal and neonatal outcomes among women with preexisting obesity and diabetes.

Methods

We conducted a retrospective cohort study using electronic health records data. Prepregnancy GLP‐1RA exposure was defined by prescription orders within 12 and 24 months prior to delivery. Propensity score matching was performed using maternal age, race and ethnicity, prepregnancy obesity status, diabetes type, chronic hypertension, insurance type, and rurality. Primary outcomes included preeclampsia (PE). Secondary outcomes included cesarean delivery, infant growth, gestational age at delivery, and neonatal intensive care unit length of stay.

Results

Among 31 exposed pregnancies, 29 were matched to unexposed controls. GLP‐1RA exposure was associated with higher prevalence of PE (12 months: p = 0.023; 24 months: p = 0.018). Cesarean delivery occurred more frequently among exposed pregnancies ( p < 0.05). No differences were observed in neonatal outcomes after matching.

Conclusions

Prepregnancy GLP‐1RA exposure was associated with higher prevalence of PE and cesarean delivery in this cohort. Larger studies are needed to confirm these findings and clarify underlying mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide-1 Receptor AgonistsObesityDiabetes Mellitus, Type 2Pre-EclampsiaHypertension, Pregnancy-InducedHypoglycemic AgentsHumansFemalePregnancyAdultRetrospective StudiesPregnancy OutcomeCesarean SectionRisk FactorsInfant, Newborn

Stichwörter der Autor:innen

GLP‐1 receptor agonistselectronic health recordsmaternal obesitypreconception carepreeclampsiahypertensive disorders of pregnancy

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Health Outcomes and Biomedical Informatics, College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Department of Obstetrics and Gynecology, College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Center for Research on Perinatal Outcomes, College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Pain Research and Intervention Center of Excellence (PRICE), University of Florida, Gainesville, Florida, USA.
  • Claude D. Pepper Older Americans Independence Center (OAIC), University of Florida, Gainesville, Florida, USA.
  • Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.

ORCID-Profile: Dominick J Lemas, Ruben Zapata, Tony Wen, Adetola Louis-Jaques, Jaclyn Hall, Larissa Strath, Serena Guo, Michelle I Cardel

Förderung

  • NIDDK NIH HHS
  • National Center for Advancing Translational Sciences of the National Institutes of Health
  • NIA NIH HHS
  • NCI NIH HHS
  • United States Association for the Study of Pain
  • Mayday Fund Clinical Translational Award
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Center for Advancing Translational Sciences

Zitieren

APA

Lemas, D. J., Zapata, R., Loy, I., Mahadevan, A., Wen, T., Mkuu, R., Louis-Jaques, A., Hall, J., Harrall, K. K., Strath, L., Sheer, A., Shenkman, E., Guo, S., Cardel, M. I., & Smith, S. (2026). Prepregnancy GLP ‐ 1RA Exposure and Risk of Hypertensive Disorders of Pregnancy Among Women With Obesity and Diabetes. Obesity. https://doi.org/10.1002/oby.70221

Vancouver

Lemas DJ, Zapata R, Loy I, Mahadevan A, Wen T, Mkuu R, et al. Prepregnancy GLP ‐ 1RA Exposure and Risk of Hypertensive Disorders of Pregnancy Among Women With Obesity and Diabetes. Obesity. 2026. doi:10.1002/oby.70221

BibTeX
@article{Lemas2026,
  author = {Lemas, Dominick J and Zapata, Ruben and Loy, Isaac and Mahadevan, Aditya and Wen, Tony and Mkuu, Rahma and Louis-Jaques, Adetola and Hall, Jaclyn and Harrall, Kylie K and Strath, Larissa and Sheer, Amy and Shenkman, Elizabeth and Guo, Serena and Cardel, Michelle I and Smith, Steve},
  title = {Prepregnancy GLP ‐ 1RA Exposure and Risk of Hypertensive Disorders of Pregnancy Among Women With Obesity and Diabetes},
  journal = {Obesity},
  year = {2026},
  doi = {10.1002/oby.70221}
}
Kostenlos starten →